Hosted on MSN10mon
Doctors develop minimally invasive procedure to avoid drilling a 'burr hole' in the skull to treat clot on the brainThe liquid embolic agent blocks—embolizes—the abnormal blood vessels that are responsible for the chronic leakage of blood onto the brain's surface.
Instylla Completes Submission of Premarket Approval Application for Embrace™ Hydrogel Embolic System
Instylla, Inc. is a privately held company based in Bedford, MA, focused on developing novel resorbable embolic agents to advance interventional radiology, with initial clinical applications in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback